Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Advantages: Greatest long-term weight loss (2540%) Strong improvements or resolution of diabetes and other conditions Considerations: Invasive with incisions Longer recovery (26 weeks) Higher surgical risks Requires lifelong dietary adjustments and vitamin supplementation GLP-1 Medications : Powerful, Non-Surgical Support GLP-1 receptor agonists (such as semaglutide and tirzepatide) are injectable medications that help reduce appetite, improve insulin sensitivity, and support weight loss
Your GP might consider: Adjusting your fluoxetine dose Switching to an alternative antidepressant with different weight effects Addressing other medications that might contribute to weight gain Never adjust or stop your medication without medical supervision, as this can lead to withdrawal symptoms or relapse of your mental health condition
Early trials show average weight loss of up to 24.2% at 48 weeks and up to 28.7% at 68 weeks higher than the average weight loss seen in trials of tirzepatide
Effects of Tesamorelin on Non-Alcoholic Fatty Liver Disease in HIV: A Randomised, Double-Blind, Multicentre Trial
US$ 29.45
US$ 22.46
US$ 23.56
US$ 28.92
US$ 25.18
US$ 24.50
US$ 23.97
US$ 22.16
US$ 21.23
